Triplet Therapeutics
A therapeutics company developing siRNA and ASO therapeutics that target repeat expansion disorders such as Huntington鈥檚 disease, myotonic dystrophy and spinocerebellar ataxias
1
Funding Rounds
$59.0m
Money raised
Overview
A therapeutics company developing siRNA and ASO therapeutics that target repeat expansion disorders such as Huntington鈥檚 disease, myotonic dystrophy and spinocerebellar ataxias
-
Website:
- Social accounts:
| Name | Phone | Social networks | |
|---|---|---|---|
| Ne**** Be*** |
|
- |
Funding series
Funding Series Analysis
The company Triplet Therapeutics has raised a total of $59m in funding over 1 rounds.
Key Insights:
- Tripley Therapeutics Series A round, December 2019: $59m
Tripley Therapeutics Series A round, December 2019
$59m
Industries
Triplet Therapeutics is active in the following industries: